Pakutanga yakaratidzwa muna 1973 naRalph Steinman naZanvil Cohn, dendritic masero (DCs) ane basa rakakosha rekuvhiringidza maitiro emukati asingatarisirwi uye kukurudzira kushanduka kwekudzivirira kwemuviri. Kubva panguva iyoyo zvichienda mberi, maDC aionekwa seakanyanya antigen-displaying masero (APCs), anowanzo kunzi "Nature's adjuvant," akagadzirirwa kutanga maitiro ekufungidzira uye asingarangariri. Panyaya yekuchengetedza nekugadzirisa maantigen ekusuma kumasero eT, maDC ane muganho wakawanda uye anoratidza huwandu husina kujairika hwemaatomu anodhura kana kuti coinhibitory anoona kutangwa kwakachengeteka kana anergy1. Makore angangoita makumi mana mushure meizvozvo, apo Mubairo weNobel weMushonga kana Physiology wakapihwa kuna Ralph Steinman muna 40 nekuda kwekuburitsa kwake aya akakosha maseru ekudzivirira emuviri, kukosha kweDCs kwakaonekwa.
ichi immunotherapy treatment helps the body battle cancer cells with its own defense mechanism. Dendritic cell therapy is often used when regular therapies have not been effective. As of late, this treatment was proposed in India and multiple patients were relieved under the supervision of the renowned Oncologist with empowering results. Be that as it may, there are common drugs that have been developed over decades for most forms of tumarara. Usage of these drugs is administered and combined with unsusceptible care, since it is realized that tumor cells weakened by chemotherapy or radiation are considerably easier to decimate with invulnerable cells than with flawless tumor cells.
Mhando yekenza inorapwa ne dendritic cell based immunotherapy kurapwa
- Kanzera reganda
- Chirwere chepyiyo
- Kansa yepabonde
- Kenza yepancreatic
- Kenza yeColon
- Ovarian cancer
- Gomarara repamberi
Kurapa kenza yechikamu IV
Dendritic cell based immunotherapy treatment has proved to be quite a success specially with no hope stage IV cancer treatment. Patients specially on stage IV cancer can try and go for dendritic cell based immunotherapy in cancer treatment.
Zvipatara zve dendritic cell based immunotherapy kurapwa muIndia
- LDG India Ltd, Gurugram
- APAC Biotech, Noida
- Dendritic tsvagiridzo yesero, New Delhi
Mutengo wedendritic cell yakavakirwa immunotherapy kurapwa muIndia
Mutengo we dendritic cell yakavakirwa immunotherapy kurapwa inogona kusiyana kubva $ 8000 USD - $ 15,000 USD zvinoenderana padanho rekenza uye kurapwa chiremba uye chipatara.
